Generic placeholder image

Current Clinical Pharmacology

Editor-in-Chief

ISSN (Print): 1574-8847
ISSN (Online): 2212-3938

Research Article

Drug Therapies for Patients with IgA Nephropathy: A Network Meta-analysis of Randomized Clinical Trials

Author(s): Kannan Sridharan* and Gowri Sivaramakrishnan

Volume 15, Issue 2, 2020

Page: [132 - 144] Pages: 13

DOI: 10.2174/1574884715666191223103914

Price: $65

Abstract

Background: Several drugs are used for treating IgA nephropathy (IgAN). We carried out a network meta-analysis evaluating these drugs.

Methods: Electronic databases were searched for appropriate randomized clinical trials carried out in patients with IgAN. The primary outcome was proteinuria remission rates and there were several other secondary outcome measures. The risk of bias was assessed. Mixed treatment comparison estimates were modelled from direct and indirect comparison estimates. Grading of the evidence for key comparisons was carried out.

Results: Fifty-seven clinical trials were included in the systematic review and 51 in the metaanalysis. Polyunsaturated fatty acids, corticosteroids/angiotensin receptor blockers (ARB), ARB, angiotensin converting enzyme inhibitors (ACEI), ARB/ACEI, corticosteroids/ACEI and hypolipidemics/ ARB were observed with significantly higher rates of proteinuria remission than the standard of care. Several benefits were observed with other drugs on the secondary outcome measures. A very low grade was observed for the interventions.

Conclusion: We observed a few interventions to perform better in the management of IgAN. The results of this study will aid in further evaluation of such drugs that may assist in saving the resources and time. However, the readers should interpret the findings with great caution as the results might change with the advent of future head-to-head clinical trials.

Keywords: Corticosteroids, immunosuppressants, angiotensin receptor blockers, angiotensin converting enzyme inhibitors, renin inhibitors, hypolipidemics.

Graphical Abstract

[1]
Julian BA, Waldo FB, Rifai A, Mestecky J. IgA nephropathy, the most common glomerulonephritis worldwide. A neglected disease in the United States? Am J Med 1988; 84(1): 129-32.
[http://dx.doi.org/10.1016/0002-9343(88)90019-8] [PMID: 3337116]
[2]
Shu D, Xu F, Su Z, et al. Risk factors of progressive IgA nephropathy which progress to end stage renal disease within ten years: a case-control study. BMC Nephrol 2017; 18(1): 11.
[http://dx.doi.org/10.1186/s12882-016-0429-x] [PMID: 28061828]
[3]
Wyatt RJ, Julian BA. IgA nephropathy. N Engl J Med 2013; 368(25): 2402-14.
[http://dx.doi.org/10.1056/NEJMra1206793] [PMID: 23782179]
[4]
Lv J, Shi S, Xu D, et al. Evaluation of the Oxford Classification of IgA nephropathy: A systematic review and meta-analysis. Am J Kidney Dis 2013; 62(5): 891-9.
[http://dx.doi.org/10.1053/j.ajkd.2013.04.021] [PMID: 23820066]
[5]
Liu Y, Ma X, Zheng J, Liu X, Yan T. A systematic review and meta-analysis of kidney and pregnancy outcomes in IgA nephropathy. Am J Nephrol 2016; 44(3): 187-93.
[http://dx.doi.org/10.1159/000446354] [PMID: 27578454]
[6]
Rauen T, Eitner F, Fitzner C, et al. STOP-IgAN Investigators. Intensive supportive care plus immunosuppression in IgA nephropathy. N Engl J Med 2015; 373(23): 2225-36.
[http://dx.doi.org/10.1056/NEJMoa1415463] [PMID: 26630142]
[7]
Kawamura T. Treatment of IgA nephropathy: Corticosteroids, tonsillectomy, and mycophenolate mofetil. Contrib Nephrol 2007; 157: 37-43.
[http://dx.doi.org/10.1159/000102286] [PMID: 17495435]
[8]
Nagy J, Sági B, Máté J, Vas T, Kovács T. Considerations on the treatment of IgA nephropathy on the basis of the results of the latest studies (STOP-IgAN, TESTING, NEFIGAN) Orv Hetil 2017; 158(49): 1946-52.
[http://dx.doi.org/10.1556/650.2017.30924]] [PMID: 29199436]
[9]
Floege J, Eitner F. Current therapy for IgA nephropathy. J Am Soc Nephrol 2011; 22(10): 1785-94.
[http://dx.doi.org/10.1681/ASN.2011030221] [PMID: 21903997]
[10]
Zhou YH, Tang LG, Guo SL, et al. Steroids in the treatment of IgA nephropathy to the improvement of renal survival: A systematic review and meta-analysis. PLoS One 2011; 6(4)e18788
[http://dx.doi.org/10.1371/journal.pone.0018788] [PMID: 21533280]
[11]
Vecchio M, Bonerba B, Palmer SC, et al. Immunosuppressive agents for treating IgA nephropathy. Cochrane Database Syst Rev 2015; (8): CD003965
[http://dx.doi.org/10.1002/14651858.CD003965.pub2] [PMID: 26235292]
[12]
Reid S, Cawthon PM, Craig JC, Samuels JA, Molony DA, Strippoli GF. Non-immunosuppressive treatment for IgA nephropathy. Cochrane Database Syst Rev 2011; (3): CD003962
[http://dx.doi.org/10.1002/14651858.CD003962.pub2] [PMID: 21412884]
[13]
Rodrigues JC, Haas M, Reich HN. IgA Nephropathy. Clin J Am Soc Nephrol 2017; 12(4): 677-86.
[http://dx.doi.org/10.2215/CJN.07420716] [PMID: 28159829]
[14]
Shim S, Yoon BH, Shin IS, Bae JM. Network meta-analysis: Application and practice using Stata. Epidemiol Health 2017; 39e2017047
[http://dx.doi.org/10.4178/epih.e2017047] [PMID: 29092392]
[15]
Hutton B, Salanti G, Caldwell DM, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: Checklist and explanations. Ann Intern Med 2015; 162(11): 777-84.
[http://dx.doi.org/10.7326/M14-2385] [PMID: 26030634]
[16]
Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions 510 edition www.cochrane-handbook.org
[17]
Sedgwick P, Marston L. How to read a funnel plot in a meta-analysis. BMJ 2015; 351(351): h4718.
[http://dx.doi.org/10.1136/bmj.h4718] [PMID: 26377337]
[18]
Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21(11): 1539-58.
[http://dx.doi.org/10.1002/sim.1186] [PMID: 12111919]
[19]
Barendregt JJ, Doi SA. MetaXL user guide http://www.epigear.com/index_files/MetaXL%20User%20Guide.pdf
[20]
Alexopoulos E, Stangou M, Pantzaki A, Kirmizis D, Memmos D. Treatment of severe IgA nephropathy with omega-3 fatty acids: the effect of a “very low dose” regimen. Ren Fail 2004; 26(4): 453-9.
[http://dx.doi.org/10.1081/JDI-200026763] [PMID: 15462115]
[21]
Ballardie FW, Roberts IS. Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy. J Am Soc Nephrol 2002; 13(1): 142-8.
[PMID: 11752031]
[22]
Bennett WM, Walker RG, Kincaid-Smith P. Treatment of IgA nephropathy with Eicosapentanoic Acid (EPA): a two-year prospective trial. Clin Nephrol 1989; 31(3): 128-31.
[PMID: 2539929]
[23]
Chan JC, Mahan JD, Trachtman H, et al. Vitamin E therapy in IgA nephropathy: A double-blind, placebo-controlled study. Pediatr Nephrol 2003; 18(10): 1015-9.
[http://dx.doi.org/10.1007/s00467-003-1205-2] [PMID: 12920628]
[24]
Chen X, Chen P, Cai G, et al. A randomized control trial of mycophenolate mofeil treatment in severe IgA nephropathy. Zhonghua Yi Xue Za Zhi 2002; 82(12): 796-801.
[PMID: 12126522]
[25]
Chen X, Qiu Q, Tang L, et al. Effects of co-administration of urokinase and benazepril on severe IgA nephropathy. Nephrol Dial Transplant 2004; 19(4): 852-7.
[http://dx.doi.org/10.1093/ndt/gfh069] [PMID: 15031340]
[26]
Cheng G, Liu D, Margetts P, et al. Valsartan combined with clopidogrel and/or leflunomide for the treatment of progressive immunoglobulin A nephropathy. Nephrology (Carlton) 2015; 20(2): 77-84.
[http://dx.doi.org/10.1111/nep.12359] [PMID: 25358874]
[27]
Coppo R, Peruzzi L, Amore A, et al. IgACE: a placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria. J Am Soc Nephrol 2007; 18(6): 1880-8.
[http://dx.doi.org/10.1681/ASN.2006040347] [PMID: 17513327]
[28]
Cruzado JM, Poveda R, Ibernón M, et al. Low-dose sirolimus combined with angiotensin-converting enzyme inhibitor and statin stabilizes renal function and reduces glomerular proliferation in poor prognosis IgA nephropathy. Nephrol Dial Transplant 2011; 26(11): 3596-602.
[http://dx.doi.org/10.1093/ndt/gfr072] [PMID: 21393611]
[29]
Donadio JV Jr, Bergstralh EJ, Offord KP, Spencer DC, Holley KE. Mayo Nephrology Collaborative Group. A controlled trial of fish oil in IgA nephropathy. N Engl J Med 1994; 331(18): 1194-9.
[http://dx.doi.org/10.1056/NEJM199411033311804] [PMID: 7935657]
[30]
Fellström BC, Barratt J, Cook H, et al. NEFIGAN trial investigators. Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): A double-blind, randomised, placebo-controlled phase 2b trial. Lancet 2017; 389(10084): 2117-27.
[http://dx.doi.org/10.1016/S0140-6736(17)30550-0] [PMID: 28363480]
[31]
Ferraro PM, Ferraccioli GF, Gambaro G, Fulignati P, Costanzi S. Combined treatment with renin-angiotensin system blockers and polyunsaturated fatty acids in proteinuric IgA nephropathy: A randomized controlled trial. Nephrol Dial Transplant 2009; 24(1): 156-60.
[http://dx.doi.org/10.1093/ndt/gfn454] [PMID: 18685141]
[32]
Frascà GM, Martello M, Sestigiani E, Canova C, Vangelista A, Bonomini V. Effects of defibrotide treatment in patients with IgA nephropathy and reduced renal function. Nephrol Dial Transplant 1996; 11(2): 392-3.
[http://dx.doi.org/10.1093/oxfordjournals.ndt.a027280] [PMID: 8700366]
[33]
Frisch G, Lin J, Rosenstock J, et al. Mycophenolate Mofetil (MMF) vs placebo in patients with moderately advanced IgA nephropathy: A double-blind randomized controlled trial. Nephrol Dial Transplant 2005; 20(10): 2139-45.
[http://dx.doi.org/10.1093/ndt/gfh974] [PMID: 16030050]
[34]
Harmankaya O, Oztürk Y, Baştürk T, Obek A, Kiliçarslan I. Efficacy of immunosuppressive therapy in IgA nephropathy presenting with isolated hematuria. Int Urol Nephrol 2002; 33(1): 167-71.
[http://dx.doi.org/10.1023/A:1014424723466] [PMID: 12090325]
[35]
Hirai K, Ookawara S, Kitano T, et al. Efficacy and safety of adding mizoribine to standard treatment in patients with immunoglobulin A nephropathy: A randomized controlled trial. Kidney Res Clin Pract 2017; 36(2): 159-66.
[http://dx.doi.org/10.23876/j.krcp.2017.36.2.159] [PMID: 28680823]
[36]
Hogg RJ, Lee J, Nardelli N, et al. Southwest Pediatric Nephrology Study Group. Clinical trial to evaluate omega-3 fatty acids and alternate day prednisone in patients with IgA nephropathy: Report from the Southwest Pediatric Nephrology Study Group. Clin J Am Soc Nephrol 2006; 1(3): 467-74.
[http://dx.doi.org/10.2215/CJN.01020905] [PMID: 17699247]
[37]
Hogg RJ, Bay RC, Jennette JC, et al. Randomized controlled trial of mycophenolate mofetil in children, adolescents, and adults with IgA nephropathy. Am J Kidney Dis 2015; 66(5): 783-91.
[http://dx.doi.org/10.1053/j.ajkd.2015.06.013] [PMID: 26209543]
[38]
Horita Y, Tadokoro M, Taura K, et al. Low-dose combination therapy with temocapril and losartan reduces proteinuria in normotensive patients with immunoglobulin a nephropathy. Hypertens Res 2004; 27(12): 963-70.
[http://dx.doi.org/10.1291/hypres.27.963] [PMID: 15894837]
[39]
Horita Y, Tadokoro M, Taura K, et al. Prednisolone co-administered with losartan confers renoprotection in patients with IgA nephropathy. Ren Fail 2007; 29(4): 441-6.
[http://dx.doi.org/10.1080/08860220701260511] [PMID: 17497466]
[40]
Hou JH, Le WB, Chen N, et al. Mycophenolate mofetil com-bined with prednisone versus full-dose prednisone in IgA nephropathy with active proliferative lesions: A randomized controlled trial. Am J Kidney Dis 2017; 69(6): 788-95.
[http://dx.doi.org/10.1053/j.ajkd.2016.11.027] [PMID: 28215945]
[41]
Li PK, Leung CB, Chow KM, et al. HKVIN Study Group. Hong Kong study using Valsartan in IgA Nephropathy (HKVIN): A double-blind, randomized, placebo-controlled study. Am J Kidney Dis 2006; 47(5): 751-60.
[http://dx.doi.org/10.1053/j.ajkd.2006.01.017] [PMID: 16632013]
[42]
Kanno Y, Witt M, Okada H, et al. A comparison of corticosteroid and warfarin therapy in IgA nephropathy with crescent formation: Preliminary trial. Clin Exp Nephrol 2003; 7(1): 48-51.
[http://dx.doi.org/10.1007/s101570300006] [PMID: 14586743]
[43]
Katafuchi R, Ikeda K, Mizumasa T, et al. Controlled, prospective trial of steroid treatment in IgA nephropathy: A limitation of low-dose prednisolone therapy. Am J Kidney Dis 2003; 41(5): 972-83.
[http://dx.doi.org/10.1016/S0272-6386(03)00194-X] [PMID: 12722031]
[44]
Kawamura T, Yoshimura M, Miyazaki Y, et al. Special IgA Nephropathy Study Group. A multicenter randomized controlled trial of tonsillectomy combined with steroid pulse therapy in patients with immunoglobulin A nephropathy. Nephrol Dial Transplant 2014; 29(8): 1546-53.
[http://dx.doi.org/10.1093/ndt/gfu020] [PMID: 24596084]
[45]
Kawasaki Y, Takano K, Suyama K, et al. Efficacy of tonsillectomy pulse therapy versus multiple-drug therapy for IgA nephropathy. Pediatr Nephrol 2006; 21(11): 1701-6.
[http://dx.doi.org/10.1007/s00467-006-0272-6] [PMID: 16932894]
[46]
Kim YC, Chin HJ, Koo HS, Kim S. Tacrolimus decreases albuminuria in patients with IgA nephropathy and normal blood pressure: A double-blind randomized controlled trial of efficacy of tacrolimus on IgA nephropathy. PLoS One 2013; 8(8)e71545
[http://dx.doi.org/10.1371/journal.pone.0071545] [PMID: 23977072]
[47]
Kloke HJ, Wetzels JF, Koene RA, Huysmans FT. Effects of low-dose nifedipine on urinary protein excretion rate in patients with renal disease. Nephrol Dial Transplant 1998; 13(3): 646-50.
[http://dx.doi.org/10.1093/ndt/13.3.646] [PMID: 9550641]
[48]
Lafayette RA, Canetta PA, Rovin BH, et al. A randomized, controlled trial of rituximab in IgA nephropathy with proteinuria and renal dysfunction. J Am Soc Nephrol 2017; 28(4): 1306-13.
[http://dx.doi.org/10.1681/ASN.2016060640] [PMID: 27821627]
[49]
Lai KN, Lai FM, Ho CP, Chan KW. Corticosteroid therapy in IgA nephropathy with nephrotic syndrome: A long-term controlled trial. Clin Nephrol 1986; 26(4): 174-80.
[PMID: 3536231]
[50]
Lee S-H, Shim JJ, Lee SH, et al. Effect of combined treatment of steroid and angiotensin II receptor blocker in proteinuric IgA nepropathy. Korean Journal of Nephrology 2003; 22: 539-45.
[51]
Liu X, Wang H, Chen W, et al. Comparison of therapeutic effect of higher-dose valsartan combined with higher dose of lotensin for IgA nephropathy. Journal of Xian Jiaotong Uni-versity 2007; 28: 437-40.
[52]
Liu H, Xu X, Fang Y, et al. Comparison of glucocorticoids alone and combined with cyclosporine a in patients with IgA nephropathy: A prospective randomized controlled trial. Intern Med 2014; 53(7): 675-81.
[http://dx.doi.org/10.2169/internalmedicine.53.1136] [PMID: 24694475]
[53]
Liu LJ, Lv JC, Shi SF, Chen YQ, Zhang H, Wang HY. Oral calcitriol for reduction of proteinuria in patients with IgA nephropathy: A randomized controlled trial. Am J Kidney Dis 2012; 59(1): 67-74.
[http://dx.doi.org/10.1053/j.ajkd.2011.09.014] [PMID: 22019331]
[54]
Lou T, Wang C, Chen Z, et al. Randomised controlled trial of leflunomide in the treatment of immunoglobulin A nephropathy. Nephrology (Carlton) 2006; 11(2): 113-6.
[http://dx.doi.org/10.1111/j.1440-1797.2006.00547.x] [PMID: 16669971]
[55]
Lv J, Zhang H, Chen Y, et al. Combination therapy of prednisone and ACE inhibitor vs. ACE-inhibitor therapy alone in patients with IgA nephropathy: A randomized controlled trial. Am J Kidney Dis 2009; 53(1): 26-32.
[http://dx.doi.org/10.1053/j.ajkd.2008.07.029] [PMID: 18930568]
[56]
Maes BD, Oyen R, Claes K, et al. Mycophenolate mofetil in IgA nephropathy: Results of a 3-year prospective placebo-controlled randomized study. Kidney Int 2004; 65(5): 1842-9.
[http://dx.doi.org/10.1111/j.1523-1755.2004.00588.x] [PMID: 15086925]
[57]
Manno C, Torres DD, Rossini M, Pesce F, Schena FP. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy. Nephrol Dial Transplant 2009; 24(12): 3694-701.
[http://dx.doi.org/10.1093/ndt/gfp356] [PMID: 19628647]
[58]
Masutani K, Tsuchimoto A, Yamada T, et al. West Japan Study Group for Therapy of IgA Nephropathy Investigators. Comparison of steroid-pulse therapy and combined with mizoribine in IgA nephropathy: A randomized controlled trial. Clin Exp Nephrol 2016; 20(6): 896-903.
[http://dx.doi.org/10.1007/s10157-016-1226-3] [PMID: 26758039]
[59]
Min L, Wang Q, Cao L, et al. Comparison of combined leflunomide and low-dose corticosteroid therapy with full-dose corticosteroid monotherapy for progressive IgA nephropathy. Oncotarget 2017; 8(29): 48375-84.
[http://dx.doi.org/10.18632/oncotarget.16468] [PMID: 28415636]
[60]
Perico N, Remuzzi A, Sangalli F, et al. The antiproteinuric effect of angiotensin antagonism in human IgA nephropathy is potentiated by indomethacin. J Am Soc Nephrol 1998; 9(12): 2308-17.
[PMID: 9848785]
[61]
Pettersson EE, Rekola S, Berglund L, et al. Treatment of IgA nephropathy with omega-3-polyunsaturated fatty acids: A prospective, double-blind, randomized study. Clin Nephrol 1994; 41(4): 183-90.
[PMID: 8026109]
[62]
Pozzi C, Bolasco PG, Fogazzi GB, et al. Corticosteroids in IgA nephropathy: A randomised controlled trial. Lancet 1999; 353(9156): 883-7.
[http://dx.doi.org/10.1016/S0140-6736(98)03563-6] [PMID: 10093981]
[63]
Pozzi C, Andrulli S, Pani A, et al. Addition of azathioprine to corticosteroids does not benefit patients with IgA nephropathy. J Am Soc Nephrol 2010; 21(10): 1783-90.
[http://dx.doi.org/10.1681/ASN.2010010117] [PMID: 20634300]
[64]
Praga M, Gutiérrez E, González E, Morales E, Hernández E. Treatment of IgA nephropathy with ACE inhibitors: A randomized and controlled trial. J Am Soc Nephrol 2003; 14(6): 1578-83.
[http://dx.doi.org/10.1097/01.ASN.0000068460.37369.DC] [PMID: 12761258]
[65]
Sato M, Takayama K, Kojima H, Koshikawa S. Sodium cromoglycate therapy in IgA nephropathy: A preliminary short-term trial. Am J Kidney Dis 1990; 15(2): 141-6.
[http://dx.doi.org/10.1016/S0272-6386(12)80511-7] [PMID: 2105638]
[66]
Shimizu A, Takei T, Uchida K, Tsuchiya K, Nitta K. Low-dose losartan therapy reduces proteinuria in normotensive patients with immunoglobulin A nephropathy. Hypertens Res 2008; 31(9): 1711-7.
[http://dx.doi.org/10.1291/hypres.31.1711] [PMID: 18971549]
[67]
Stangou M, Ekonomidou D, Giamalis P, et al. Steroids and azathioprine in the treatment of IgA nephropathy. Clin Exp Nephrol 2011; 15(3): 373-80.
[http://dx.doi.org/10.1007/s10157-011-0415-3] [PMID: 21301920]
[68]
Szeto CC, Kwan BC, Chow KM, Leung CB, Li PK. The safety and short-term efficacy of aliskiren in the treatment of immunoglobulin a nephropathy-A randomized cross-over study. PLoS One 2013; 8(5)e62736
[http://dx.doi.org/10.1371/journal.pone.0062736] [PMID: 23675422]
[69]
Tang S, Leung JC, Chan LY, et al. Mycophenolate mofetil alleviates persistent proteinuria in IgA nephropathy. Kidney Int 2005; 68(2): 802-12.
[http://dx.doi.org/10.1111/j.1523-1755.2005.00460.x] [PMID: 16014059]
[70]
Walker RG, Yu SH, Owen JE, Kincaid-Smith P. The treatment of mesangial IgA nephropathy with cyclophosphamide, dipyridamole and warfarin: a two-year prospective trial. Clin Nephrol 1990; 34(3): 103-7.
[PMID: 2225560]
[71]
Woo KT, Chan CM, Tan HK, et al. Beneficial effects of high-dose losartan in IgA nephritis. Clin Nephrol 2009; 71(6): 617-24.
[http://dx.doi.org/10.5414/CNP71617] [PMID: 19473629]
[72]
Wu J, Duan SW, Sun XF, et al. Efficacy of leflunomide, telmisartan, and clopidogrel for immunoglobulin A nephropa-thy: A randomized controlled trial. Chin Med J (Engl) 2016; 129(16): 1894-903.
[http://dx.doi.org/10.4103/0366-6999.187848] [PMID: 27503012]
[73]
Xie Y, Huang S, Wang L, et al. Efficacy and safety of mizoribine combined with losartan in the treatment of IgA nephropathy: A multicenter, randomized, controlled study. Am J Med Sci 2011; 341(5): 367-72.
[http://dx.doi.org/10.1097/MAJ.0b013e318207e02d] [PMID: 21293249]
[74]
Ye Z, Zhang L, Xu L, et al. Probucol combined with valsartan in immunoglobulin A nephropathy: A multi-centre, open labelled, randomized controlled study. Nephrology (Carlton) 2014; 19(1): 40-6.
[http://dx.doi.org/10.1111/nep.12177] [PMID: 24191893]
[75]
Yoshikawa N, Ito H, Sakai T, et al. A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. The Japanese Pediatric IgA Nephropathy Treatment Study Group. J Am Soc Nephrol 1999; 10(1): 101-9.
[PMID: 9890315]
[76]
Yoshikawa N, Honda M, Iijima K, et al. Japanese Pediatric IgA Nephropathy Treatment Study Group. Steroid treatment for severe childhood IgA nephropathy: A randomized, controlled trial. Clin J Am Soc Nephrol 2006; 1(3): 511-7.
[http://dx.doi.org/10.2215/CJN.01120905] [PMID: 17699253]
[77]
Yang P, Zou H, Xiao B, Xu G. Comparative efficacy and safe-ty of therapies in IgA nephropathy. A network meta-analysis of randomized controlled trials. Kidney Int Rep 2018; 3(4): 794-803.
[http://dx.doi.org/10.1016/j.ekir.2018.03.006] [PMID: 29989013]
[78]
Radhakrishnan J, Cattran DC. The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines-Application to the individual patient. Kidney Int 2012; 82(8): 840-56.
[http://dx.doi.org/10.1038/ki.2012.280] [PMID: 22895519]
[79]
Ohashi N, Urushihara M, Kobori H. Activated intrarenal reactive oxygen species and renin angiotensin system in IgA nephropathy. Minerva Urol Nefrol 2009; 61(1): 55-66.
[PMID: 19417726]
[80]
Lv J, Xu D, Perkovic V, et al. TESTING Study Group. Corticosteroid therapy in IgA nephropathy. J Am Soc Nephrol 2012; 23(6): 1108-16.
[http://dx.doi.org/10.1681/ASN.2011111112] [PMID: 22539830]
[81]
Zhang Y, Luo J, Hu B, Ma T. Efficacy and safety of tacrolimus combined with glucocorticoid treatment for IgA nephropathy: A meta-analysis. J Int Med Res 2018; 46(8): 3236-50.
[http://dx.doi.org/10.1177/0300060518776566] [PMID: 29882450]
[82]
Kidney Disease Improving Global Outcomes clinical practice guidelines for glomerulonephritis http://www.kdigo.org/clinical_practice_guidelines/pdf/KDIGO%20GN%20Suppl%20Online%20Tables%20May%202012.pdf [Accessed on 27th November 2018]..
[83]
Jin SY, Choi IJ. The effect of sodium cromoglycate on the induction of experimental IgA nephropathy. Yonsei Med J 1990; 31(1): 33-48.
[http://dx.doi.org/10.3349/ymj.1990.31.1.33] [PMID: 2111960]
[84]
Bazzi C, Sinico RA, Petrini C, et al. Low doses of drugs able to alter intestinal mucosal permeability to food antigens (5-aminosalicylic acid and sodium cromoglycate) do not reduce proteinuria in patients with IgA nephropathy: A preliminary noncontrolled trial. Nephron 1992; 61(2): 192-5.
[http://dx.doi.org/10.1159/000186870] [PMID: 1630544]
[85]
Coppo R. Corticosteroids in IgA nephropathy: Lessons from recent studies. J Am Soc Nephrol 2017; 28(1): 25-33.
[http://dx.doi.org/10.1681/ASN.2016060647] [PMID: 27671778]
[86]
Lai KN, Chan LY, Tang SC, et al. Mesangial expression of angiotensin II receptor in IgA nephropathy and its regulation by polymeric IgA1. Kidney Int 2004; 66(4): 1403-16.
[http://dx.doi.org/10.1111/j.1523-1755.2004.00874.x] [PMID: 15458433]
[87]
Jafar TH, Stark PC, Schmid CH, et al. AIPRD Study Group. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: A patient-level meta-analysis. Ann Intern Med 2003; 139(4): 244-52.
[http://dx.doi.org/10.7326/0003-4819-139-4-200308190-00006] [PMID: 12965979]

Rights & Permissions Print Cite
© 2025 Bentham Science Publishers | Privacy Policy
Request history8.2.27PHP Version269msRequest Duration28MBMemory UsageGET article/{article_id}/{param?}Route
  • warninglog[21:58:50] LOG.warning: Optional parameter $article_id declared before required parameter $request i...
  • warninglog[21:58:51] LOG.warning: trim(): Passing null to parameter #1 ($string) of type string is deprecated ...
  • warninglog[21:58:51] LOG.warning: Function strftime() is deprecated in /home/alphaeurekaselec/public_html/stor...
  • Booting (111ms)time
  • Application (158ms)time
  • 1 x Application (58.86%)
    158ms
    1 x Booting (41.14%)
    111ms
    12 templates were rendered
    • articlearticle.blade.php#?blade
    • includes.article_top_bannerarticle_top_banner.blade.php#?blade
    • includes.article_referencearticle_reference.blade.php#?blade
    • export_citation_formexport_citation_form.blade.php#?blade
    • includes.article_bottom_bannerarticle_bottom_banner.blade.php#?blade
    • includes.inc_related_journalsinc_related_journals.blade.php#?blade
    • includes.inc_related_ebooksinc_related_ebooks.blade.php#?blade
    • layouts.appapp.blade.php#?blade
    • layouts._login_access_login_access.blade.php#?blade
    • layouts._header_header.blade.php#?blade
    • layouts._main_menu_main_menu.blade.php#?blade
    • layouts._footer_menu_footer_menu.blade.php#?blade
    uri
    GET article/{article_id}/{param?}
    middleware
    web, check_user_access
    controller
    App\Http\Controllers\ArticleController@GetArticleDetails
    namespace
    App\Http\Controllers
    where
    as
    article
    file
    app/Http/Controllers/ArticleController.php:1974-2510
    35 statements were executed, 2 of which were duplicates, 33 unique. Show only duplicated85.62ms
    • Connection Establishedalphaeurekaselec_live_10_06_2022UserAccessCheck.php#24
      Backtrace
      • 9. middleware::check_user_access:24
      • 10. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 11. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 12. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 13. vendor/laravel/framework/src/Illuminate/Foundation/Http/Middleware/VerifyCsrfToken.php:88
    • INSERT INTO visitor_ip_address (ip_address,visitor_agent,visitor_count, created_on,updated_on) VALUES ('59576018','',1,1740347930,1740347930) ON DUPLICATE KEY UPDATE visitor_count=visitor_count + 1, updated_on=1740347930
      940μsalphaeurekaselec_live_10_06_2022UserAccessCheck.php#24
      Backtrace
      • 11. middleware::check_user_access:24
      • 12. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 14. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 15. vendor/laravel/framework/src/Illuminate/Foundation/Http/Middleware/VerifyCsrfToken.php:88
    • INSERT INTO visitor_ip_address_detail (ip_address,visitor_url,visitor_count, created_on,updated_on) VALUES ('59576018','/article/103135',1,1740347930,1740347930)
      200μsalphaeurekaselec_live_10_06_2022UserAccessCheck.php#27
      Backtrace
      • 11. middleware::check_user_access:27
      • 12. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 14. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 15. vendor/laravel/framework/src/Illuminate/Foundation/Http/Middleware/VerifyCsrfToken.php:88
    • (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_journal_volume_trail WHERE to_ip >= 59576018 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59576018) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_journal_volume_corporate WHERE to_ip >= 59576018 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59576018) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_journal_volume_token WHERE to_ip >= 59576018 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59576018) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_ebook_volume_trail WHERE to_ip >= 59576018 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59576018) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_ebook_volume_corporate WHERE to_ip >= 59576018 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59576018) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_ebook_volume_token WHERE to_ip >= 59576018 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59576018) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_issue_trail WHERE to_ip >= 59576018 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59576018) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_issue_corporate WHERE to_ip >= 59576018 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59576018) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_issue_token WHERE to_ip >= 59576018 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59576018) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_article_trail WHERE to_ip >= 59576018 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59576018) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_article_corporate WHERE to_ip >= 59576018 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59576018) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_article_token WHERE to_ip >= 59576018 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59576018) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_chapter_trail WHERE to_ip >= 59576018 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59576018) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_chapter_corporate WHERE to_ip >= 59576018 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59576018) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_chapter_token WHERE to_ip >= 59576018 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59576018) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_disease_corporate WHERE to_ip >= 59576018 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59576018) limit 1
      17.77msalphaeurekaselec_live_10_06_2022UserAccess.php#784
      Bindings
      • 0: 59576018
      • 1: 59576018
      • 2: 59576018
      • 3: 59576018
      • 4: 59576018
      • 5: 59576018
      • 6: 59576018
      • 7: 59576018
      • 8: 59576018
      • 9: 59576018
      • 10: 59576018
      • 11: 59576018
      • 12: 59576018
      • 13: 59576018
      • 14: 59576018
      • 15: 59576018
      Backtrace
      • 14. app/Models/UserAccess/UserAccess.php:784
      • 15. middleware::check_user_access:114
      • 16. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 18. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
    • SELECT at.type_name, p.copyright, p.publisher_location,m.month,y.year, a.publish_on, a.nid article_nid,a.article_id, a.pmid, a.issue_id, a.title, a.abstract,a.podcast,a.altmetric_score,a.altmetric_url,a.kudos_url, a.page_count, a.first_page, a.elocator, a.last_page, i.publication_date, a.file_name, a.file_path, a.doi, a.is_epub,a.epub_type, a.volume_id, a.is_uploaded, a.editor_choice, a.is_epub, j.image_file_name, a.article_no, a.art_type AS article_type, a.supplementary_filename,a.html_filename,a.prc_filename,a.epub_filename, a.graph_abs_lg_filename, a.graph_abs_sm_filename, a.oa_image_lg_filename, a.oa_image_sm_filename, j.journal_banner,a.animated_abstract,a.erratum_in,a.erratum_for, (CASE WHEN a.issue_id =0 THEN j.epub_price ELSE j.price END) AS sell_price, j.epub_price, j.nid AS jour_nid, j.title AS journal_title, j.issn, j.eissn,j.journal_id, j.subtitle AS jour_subtitle, v.volume_id,v.volume_name AS volume, v.year_id, i.title AS issue, i.month_id ,i.type issue_type, j.subtitle,j.formerly_title, ac.subtitle AS epub_title,a.crossmark_enabled,a.text_mining_urls,a.license_urls,a.created, a.receivedate, a.revisedate, a.acceptdate,js.js_title FROM article a LEFT JOIN article_section ac ON a.is_epub = ac.art_sec_id LEFT JOIN journal_section js ON a.js_id = js.js_id LEFT JOIN article_type at ON a.art_type = at.art_type_id LEFT JOIN issue i ON a.issue_id = i.issue_id LEFT JOIN month m ON m.id = i.month_id LEFT JOIN volume v ON v.volume_id = a.volume_id INNER JOIN year y ON y.id = v.year_id INNER JOIN journal j ON j.journal_id = a.journal_id INNER JOIN publisher p ON p.publisher_id = j.publisher_id WHERE a.article_id=103135
      730μsalphaeurekaselec_live_10_06_2022Article.php#408
      Backtrace
      • 11. app/Models/Article.php:408
      • 12. app/Http/Controllers/ArticleController.php:2515
      • 13. app/Http/Controllers/ArticleController.php:2035
      • 14. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 15. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select * from `journal` where `journal_id` = 12 limit 1
      840μsalphaeurekaselec_live_10_06_2022Journal.php#64
      Bindings
      • 0: 12
      Backtrace
      • 14. app/Models/Journal.php:64
      • 15. app/Http/Controllers/ArticleController.php:2516
      • 16. app/Http/Controllers/ArticleController.php:2035
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select count(*) as aggregate from (select j.nid as journal_nid,j.flyer_link,j.title ,j.issn,j.eissn,j.keyword, j.journal_id as journal_id, j.subtitle, j.image_file_name,j.description,j.journal_insight_url,j.doi from `subject_journal` as `sj` inner join `journal` as `j` on `j`.`journal_id` = `sj`.`journal_id` where j.journal_status=1 and subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=12) and sj.journal_id!=12 group by `j`.`nid`) as `aggregate_table`
      950μsalphaeurekaselec_live_10_06_2022Subject.php#200
      Backtrace
      • 16. app/Models/Subject.php:200
      • 17. app/Http/Controllers/ArticleController.php:2517
      • 18. app/Http/Controllers/ArticleController.php:2035
      • 19. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 20. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select j.nid as journal_nid,j.flyer_link,j.title ,j.issn,j.eissn,j.keyword, j.journal_id as journal_id, j.subtitle, j.image_file_name,j.description,j.journal_insight_url,j.doi from `subject_journal` as `sj` inner join `journal` as `j` on `j`.`journal_id` = `sj`.`journal_id` where j.journal_status=1 and subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=12) and sj.journal_id!=12 group by `j`.`nid` order by `j`.`journal_id` asc limit 10 offset 0
      800μsalphaeurekaselec_live_10_06_2022Subject.php#200
      Backtrace
      • 14. app/Models/Subject.php:200
      • 15. app/Http/Controllers/ArticleController.php:2517
      • 16. app/Http/Controllers/ArticleController.php:2035
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select count(*) as aggregate from (select v.nid as volume_id,e.nid,e.title,v.issn,v.eissn,v.isbn,v.eisbn,e.ebook_id, v.image_file_name,v.file_path,v.flyer_link,v.ebook_volume_id, v.volume_name,v.doi,v.year_id,v.introduction from `subject_ebook` as `se` inner join `ebook` as `e` on `e`.`ebook_id` = `se`.`ebook_id` inner join `ebook_volume` as `v` on `v`.`ebook_id` = `se`.`ebook_id` inner join `year` as `y` on `y`.`id` = `v`.`year_id` where subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=12) and v.ebook_status='1' and y.year > 2020 group by `v`.`nid`) as `aggregate_table`
      930μsalphaeurekaselec_live_10_06_2022Subject.php#220
      Backtrace
      • 16. app/Models/Subject.php:220
      • 17. app/Http/Controllers/ArticleController.php:2518
      • 18. app/Http/Controllers/ArticleController.php:2035
      • 19. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 20. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select v.nid as volume_id,e.nid,e.title,v.issn,v.eissn,v.isbn,v.eisbn,e.ebook_id, v.image_file_name,v.file_path,v.flyer_link,v.ebook_volume_id, v.volume_name,v.doi,v.year_id,v.introduction from `subject_ebook` as `se` inner join `ebook` as `e` on `e`.`ebook_id` = `se`.`ebook_id` inner join `ebook_volume` as `v` on `v`.`ebook_id` = `se`.`ebook_id` inner join `year` as `y` on `y`.`id` = `v`.`year_id` where subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=12) and v.ebook_status='1' and y.year > 2020 group by `v`.`nid` order by `v`.`ebook_volume_id` desc limit 10 offset 0
      860μsalphaeurekaselec_live_10_06_2022Subject.php#220
      Backtrace
      • 14. app/Models/Subject.php:220
      • 15. app/Http/Controllers/ArticleController.php:2518
      • 16. app/Http/Controllers/ArticleController.php:2035
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select * from `keywords` where `article_id` = '103135'
      360μsalphaeurekaselec_live_10_06_2022Keywords.php#43
      Bindings
      • 0: 103135
      Backtrace
      • 13. app/Models/Keywords.php:43
      • 14. app/Http/Controllers/ArticleController.php:2519
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select * from `article_citation` where `article_id` = '103135'
      4.01msalphaeurekaselec_live_10_06_2022Article.php#1570
      Bindings
      • 0: 103135
      Backtrace
      • 13. app/Models/Article.php:1570
      • 14. app/Http/Controllers/ArticleController.php:2520
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select CONCAT_WS(' ',au.first_name, ' ', ifnull(au.initials,''), ' ', au.last_name) as authors, CONCAT(au.last_name, IFNULL(CONCAT(' ', au.initials), ''), ' ', au.first_name) AS authorsRIS, CONCAT_WS(' ',au.last_name, ' ', ifnull(au.initials,''), ' ', au.first_name) as authorsCiteAs, CONCAT_WS(' ',au.first_name, IFNULL(CONCAT(' ', au.initials), ''), IFNULL(CONCAT(' ', au.last_name), '')) as authorsmodal , `au`.*, `af`.`ror_id`, `af`.`institution`, `af`.`department`, `af`.`country`, `af`.`city`, `af`.`address`, (GROUP_CONCAT(TRIM(BOTH ', ' FROM CONCAT(ifnull(concat(af.institution,','),''), ifnull(concat(af.department,','),''), ifnull(concat(af.address,','),''), ifnull(concat(af.city,','),''), ifnull(concat(af.country,','),''), ifnull(concat(af.postal_code,','),''), ifnull(concat(af.phone,','),''), ifnull(concat(af.fax,','),''))) SEPARATOR '|')) as `author_affiliation`, (GROUP_CONCAT(TRIM(BOTH ', ' FROM CONCAT(ifnull(concat(af.web_view,','),''))) SEPARATOR '|')) as `web_view` from `author` as `au` left join `author_affiliation` as `af` on `au`.`author_id` = `af`.`author_id` where `au`.`article_id` = '103135' group by `au`.`author_id` order by `au`.`article_id` asc, `au`.`sequence` asc
      1.99msalphaeurekaselec_live_10_06_2022Author.php#86
      Bindings
      • 0: 103135
      Backtrace
      • 13. app/Models/Author.php:86
      • 14. app/Http/Controllers/ArticleController.php:2533
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select `bo`.* from `bundle_offer` as `bo` where `bo`.`bundle_status` = 'A' order by `bo`.`bundle_id` desc
      250μsalphaeurekaselec_live_10_06_2022BundleOffer.php#57
      Bindings
      • 0: A
      Backtrace
      • 13. app/Models/BundleOffer.php:57
      • 14. app/Http/Controllers/ArticleController.php:2535
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select `subtitle` from `journal` where `continues_publication_journal` = 1
      460μsalphaeurekaselec_live_10_06_2022Article.php#1960
      Bindings
      • 0: 1
      Backtrace
      • 13. app/Models/Article.php:1960
      • 14. app/Http/Controllers/ArticleController.php:2062
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • Select j.subtitle, v.volume_id as volume_id,v.year_id,y.year as year,v.volume_name, v.total_no_of_issues, i.issue_id as issue_id,i.title as issue, i.publication_date as issue_pub_date from journal j join volume v on j.journal_id = v.journal_id join issue i on v.volume_id = i.volume_id join article a on a.issue_id = i.issue_id join year y on v.year_id = y.id where j.journal_id = 12 and i.is_uploaded = 1 order by v.volume_name+0 desc, i.title+0 desc limit 1
      32.23msalphaeurekaselec_live_10_06_2022Issue.php#298
      Backtrace
      • 11. app/Models/Issue.php:298
      • 12. app/Http/Controllers/ArticleController.php:2068
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select a.nid,a.publish_on, a.pmid,a.article_id,a.doi,j.journal_id,j.subtitle,v.volume_name,a.volume_id as volume_id, a.issue_id,a.title,first_page, last_page, page_count,abstract,ifnull(is_abstract,"y"),asec.title as article_section,at.type_name as article_type_name, a.article_id as ArticleID ,is_epub,epub_price,epub_type,a.created, y.year from `article` as `a` left join `article_section` as `asec` on `asec`.`art_sec_id` = `a`.`is_epub` left join `article_type` as `at` on `at`.`art_type_id` = `a`.`art_type` left join `journal` as `j` on `j`.`journal_id` = `a`.`journal_id` inner join `volume` as `v` on `a`.`volume_id` = `v`.`volume_id` inner join `year` as `y` on `v`.`year_id` = `y`.`id` where a.article_status != "W" and a.is_epub = 1 and a.journal_id = 12 and a.is_uploaded = 1 group by `a`.`article_id` order by `a`.`publish_on` desc
      2.59msalphaeurekaselec_live_10_06_2022Article.php#528
      Backtrace
      • 13. app/Models/Article.php:528
      • 14. app/Http/Controllers/ArticleController.php:2070
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select a.nid,a.publish_on, a.pmid,a.article_id,a.doi,j.journal_id,j.subtitle,v.volume_name,a.volume_id as volume_id, a.issue_id,a.title,first_page, last_page, page_count,abstract,ifnull(is_abstract,"y"),asec.title as article_section,at.type_name as article_type_name, a.article_id as ArticleID ,is_epub,epub_price,epub_type,a.created, y.year from `article` as `a` left join `article_section` as `asec` on `asec`.`art_sec_id` = `a`.`is_epub` left join `article_type` as `at` on `at`.`art_type_id` = `a`.`art_type` left join `journal` as `j` on `j`.`journal_id` = `a`.`journal_id` inner join `volume` as `v` on `a`.`volume_id` = `v`.`volume_id` inner join `year` as `y` on `v`.`year_id` = `y`.`id` where a.article_status != "W" and a.is_epub = 4 and a.journal_id = 12 and a.is_uploaded = 1 group by `a`.`article_id` order by `a`.`publish_on` desc
      2.35msalphaeurekaselec_live_10_06_2022Article.php#528
      Backtrace
      • 13. app/Models/Article.php:528
      • 14. app/Http/Controllers/ArticleController.php:2071
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select pdf, html, epub, prc from `article_metrics` where `article_id` = 103135 limit 1
      220μsalphaeurekaselec_live_10_06_2022Article.php#744
      Bindings
      • 0: 103135
      Backtrace
      • 14. app/Models/Article.php:744
      • 15. app/Http/Controllers/ArticleController.php:2091
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from content_by_diseases where content_id = 103135 and content_type = 'article' order by status desc limit 1
      230μsalphaeurekaselec_live_10_06_2022Article.php#751
      Backtrace
      • 11. app/Models/Article.php:751
      • 12. app/Http/Controllers/ArticleController.php:2094
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `node_meta` where `nid` = 177689 limit 1
      220μsalphaeurekaselec_live_10_06_2022Meta.php#30
      Bindings
      • 0: 177689
      Backtrace
      • 14. app/Models/Meta.php:30
      • 15. app/Http/Controllers/ArticleController.php:2101
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select `bo`.* from `bundle_offer` as `bo` where `bo`.`bundle_status` = 'A' order by `bo`.`bundle_id` desc
      230μsalphaeurekaselec_live_10_06_2022BundleOffer.php#57
      Bindings
      • 0: A
      Backtrace
      • 13. app/Models/BundleOffer.php:57
      • 14. app/Http/Controllers/ArticleController.php:2108
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `tbl_ht_submission` as `h` where `h`.`subtitle` = 'CCP' and (h.proposal_closing_date = 0 OR TO_DAYS(FROM_UNIXTIME(h.proposal_closing_date)) >= TO_DAYS(NOW())) order by `h`.`manuscript` asc
      320μsalphaeurekaselec_live_10_06_2022Article.php#2025
      Bindings
      • 0: CCP
      Backtrace
      • 13. app/Models/Article.php:2025
      • 14. app/Http/Controllers/ArticleController.php:2112
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select count(*) as total_count, content_type_access_id as access_type from journal_access where content_type_id = '103135' and content_type = 'a' and ( (from_date <= CURDATE() and to_date >= CURDATE() and perpetual= 0) or (from_date is null and to_date is null and perpetual= 1) )
      510μsalphaeurekaselec_live_10_06_2022ContentAccess.php#647
      Backtrace
      • 11. app/Models/ContentAccess.php:647
      • 12. app/Http/Controllers/ArticleController.php:2186
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select count(*) as total_count, content_type_access_id as access_type from journal_access where content_type_id = '10045' and content_type = 'i' and ( (from_date <= CURDATE() and to_date >= CURDATE() and perpetual= 0) or (from_date is null and to_date is null and perpetual= 1) )
      390μsalphaeurekaselec_live_10_06_2022ContentAccess.php#647
      Backtrace
      • 11. app/Models/ContentAccess.php:647
      • 12. app/Http/Controllers/ArticleController.php:2207
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select count(*) as total_count, content_type_access_id as access_type from journal_access where content_type_id = '2744' and content_type = 'v' and ( (from_date <= CURDATE() and to_date >= CURDATE() and perpetual= 0) or (from_date is null and to_date is null and perpetual= 1) )
      360μsalphaeurekaselec_live_10_06_2022ContentAccess.php#647
      Backtrace
      • 11. app/Models/ContentAccess.php:647
      • 12. app/Http/Controllers/ArticleController.php:2231
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Trial Access" as access_base_text, CASE j.type WHEN 111 THEN true ELSE false END as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"volume" as access_level,"" as issue_id,"" as article_id from `user_access_journal_volume_trail` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 59576018 and j.to_ip >=59576018 )) and ((j.from_date <= 1740347931 and j.to_date >= 1740347931 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.volume_id = 2744) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Subscribed" as access_base_text, false as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"volume" as access_level,"" as issue_id,"" as article_id from `user_access_journal_volume_corporate` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 59576018 and j.to_ip >=59576018 )) and ((j.from_date <= 1740347931 and j.to_date >= 1740347931 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.volume_id = 2744) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Token Based Access" as access_base_text, false as terms_popup, "R" as content_download_type, j.uc_id as restricted_user_access_key, "v" as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"volume" as access_level,"" as issue_id,"" as article_id from `user_access_journal_volume_token` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 59576018 and j.to_ip >=59576018 )) and ((j.from_date <= 1740347931 and j.to_date >= 1740347931 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.volume_id = 2744)
      6.57msalphaeurekaselec_live_10_06_2022UserAccess.php#1266
      Backtrace
      • 13. app/Models/UserAccess/UserAccess.php:1266
      • 14. app/Http/Controllers/ArticleController.php:2272
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Trial Access" as access_base_text, CASE j.type WHEN 111 THEN true ELSE false END as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"issue" as access_level,j.issue_id,"" as article_id from `user_access_issue_trail` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 59576018 and j.to_ip >=59576018 )) and ((j.from_date <= 1740347931 and j.to_date >= 1740347931 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.issue_id = 10045) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Subscribed" as access_base_text, false as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"issue" as access_level,j.issue_id,"" as article_id from `user_access_issue_corporate` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 59576018 and j.to_ip >=59576018 )) and ((j.from_date <= 1740347931 and j.to_date >= 1740347931 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.issue_id = 10045) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Token Based Access" as access_base_text, false as terms_popup, "R" as content_download_type, j.uc_id as restricted_user_access_key, "v" as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"issue" as access_level,j.issue_id,"" as article_id from `user_access_issue_token` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 59576018 and j.to_ip >=59576018 )) and ((j.from_date <= 1740347931 and j.to_date >= 1740347931 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.issue_id = 10045)
      810μsalphaeurekaselec_live_10_06_2022UserAccess.php#1266
      Backtrace
      • 13. app/Models/UserAccess/UserAccess.php:1266
      • 14. app/Http/Controllers/ArticleController.php:2297
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Trial Access" as access_base_text, CASE j.type WHEN 111 THEN true ELSE false END as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"article" as access_level, j.issue_id, j.article_id from `user_access_article_trail` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 59576018 and j.to_ip >=59576018 )) and ((j.from_date <= 1740347931 and j.to_date >= 1740347931 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.article_id = 103135) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Subscribed" as access_base_text, false as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"article" as access_level, j.issue_id, j.article_id from `user_access_article_corporate` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 59576018 and j.to_ip >=59576018 )) and ((j.from_date <= 1740347931 and j.to_date >= 1740347931 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.article_id = 103135) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Token Based Access" as access_base_text, false as terms_popup, "R" as content_download_type, j.uc_id as restricted_user_access_key, "v" as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"article" as access_level, j.issue_id, j.article_id from `user_access_article_token` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 59576018 and j.to_ip >=59576018 )) and ((j.from_date <= 1740347931 and j.to_date >= 1740347931 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.article_id = 103135)
      780μsalphaeurekaselec_live_10_06_2022UserAccess.php#1266
      Backtrace
      • 13. app/Models/UserAccess/UserAccess.php:1266
      • 14. app/Http/Controllers/ArticleController.php:2329
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `article` where `first_page` < '132' and is_uploaded = 1 and issue_id = 10045 order by cast(first_page as SIGNED) desc limit 1
      640μsalphaeurekaselec_live_10_06_2022Article.php#1819
      Bindings
      • 0: 132
      Backtrace
      • 14. app/Models/Article.php:1819
      • 15. app/Http/Controllers/ArticleController.php:2470
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `article` where `last_page` > '144' and is_uploaded = 1 and issue_id = 10045 order by cast(first_page as SIGNED) asc limit 1
      520μsalphaeurekaselec_live_10_06_2022Article.php#1831
      Bindings
      • 0: 144
      Backtrace
      • 14. app/Models/Article.php:1831
      • 15. app/Http/Controllers/ArticleController.php:2472
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select `language_id` from `multilanguage` where `short_code` = 'en'
      200μsalphaeurekaselec_live_10_06_2022ArticleController.php#2497
      Bindings
      • 0: en
      Backtrace
      • 14. app/Http/Controllers/ArticleController.php:2497
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:206
    • select `source_lang_label`, `target_lang_label` from `multilanguage_labels` where `target_lang_id` = 1
      240μsalphaeurekaselec_live_10_06_2022MultiLanguage.php#23
      Bindings
      • 0: 1
      Backtrace
      • 13. app/Models/MultiLanguage.php:23
      • 14. app/Http/Controllers/ArticleController.php:2498
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select `id` from `multilanguage_article` where `article_id` = 103135 limit 1
      3.25msalphaeurekaselec_live_10_06_2022ArticleController.php#2506
      Bindings
      • 0: 103135
      Backtrace
      • 16. app/Http/Controllers/ArticleController.php:2506
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 19. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
      • 20. vendor/laravel/framework/src/Illuminate/Routing/Route.php:206
    • select b.banner_link, b.banner_name, b.banner_script, b.banner_remarks, b.banner_file_name, b.banner_placement, bd.content_type, bd.content_id from `tbl_banner` as `b` inner join `tbl_banner_detail` as `bd` on `bd`.`banner_id` = `b`.`banner_id` inner join `users` as `u` on `u`.`id` = `b`.`updated_by` inner join `journal` as `j` on `j`.`journal_id` = `bd`.`content_id` where `b`.`banner_journal` = 1 and `bd`.`content_type` = 'J' and `bd`.`content_id` = 12 and `b`.`banner_from_date` <= 1740347931 and `b`.`banner_to_date` >= 1740347931 and `b`.`banner_status` = 'A' order by `b`.`banner_id` desc
      1.62msalphaeurekaselec_live_10_06_2022Banner.php#95
      Bindings
      • 0: 1
      • 1: J
      • 2: 12
      • 3: 1740347931
      • 4: 1740347931
      • 5: A
      Backtrace
      • 13. app/Models/Banner.php:95
      • 14. app/Http/helpers.php:404
      • 17. vendor/laravel/framework/src/Illuminate/Filesystem/Filesystem.php:124
      • 18. vendor/laravel/framework/src/Illuminate/View/Engines/PhpEngine.php:58
      • 19. vendor/laravel/framework/src/Illuminate/View/Engines/CompilerEngine.php:73
    • select count(*) as aggregate from `uc_cart_products` where cart_id='a4ff9f5d16b59bdb5577eb20140616d7'
      250μsalphaeurekaselec_live_10_06_2022Cart.php#271
      Backtrace
      • 15. app/Models/Cart.php:271
      • 16. view::layouts._header:260
      • 18. vendor/laravel/framework/src/Illuminate/Filesystem/Filesystem.php:124
      • 19. vendor/laravel/framework/src/Illuminate/View/Engines/PhpEngine.php:58
      • 20. vendor/laravel/framework/src/Illuminate/View/Engines/CompilerEngine.php:73
    App\Models\MultiLanguage
    1MultiLanguage.php#?
        _token
        Wu0t6w6oFrXwYSdOKrA2ttnYuSQJE3xmxaZWFUka
        uc_cart_id
        a4ff9f5d16b59bdb5577eb20140616d7
        _previous
        array:1 [ "url" => "http://alpha.eurekaselect.com/article/103135" ]
        _flash
        array:2 [ "old" => [] "new" => [] ]
        PHPDEBUGBAR_STACK_DATA
        []
        path_info
        /article/103135
        status_code
        200
        
        status_text
        OK
        format
        html
        content_type
        text/html; charset=UTF-8
        request_query
        []
        
        request_request
        []
        
        request_headers
        0 of 0
        array:9 [ "cookie" => array:1 [ 0 => "wayfindertarget=eyJpdiI6IkZ2Y0NSWjVrT0MzVjRCMmg0cUMySnc9PSIsInZhbHVlIjoiR0RRa3lPeCsxYjhMQjNhRWlBTXhDWXhONTQyT0tLSGxQaXdwVERPTUhPZz0iLCJtYWMiOiIzNmQwYTY5NDkxZDRhMGZjZjg3YzkzNWFjY2U2ZGU0Y2IzZTQ4NGJlMGYxYzA1MTIyMThiYWIwNjc3NThiZTliIiwidGFnIjoiIn0%3Dwayfindertarget=eyJpdiI6IkZ2Y0NSWjVrT0MzVjRCMmg0cUMySnc9PSIsInZhbHVlIjoiR0RRa3lPeCsxYjhMQjNhRWlBTXhDWXhONTQyT0tLSGxQaXdwVERPTUhPZz0iLCJtYWMiOiIzNmQwYTY5NDkxZDRh" ] "accept-encoding" => array:1 [ 0 => "gzip, deflate" ] "accept" => array:1 [ 0 => "text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.7" ] "user-agent" => array:1 [ 0 => "Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)" ] "upgrade-insecure-requests" => array:1 [ 0 => "1" ] "cache-control" => array:1 [ 0 => "no-cache" ] "pragma" => array:1 [ 0 => "no-cache" ] "connection" => array:1 [ 0 => "keep-alive" ] "host" => array:1 [ 0 => "alpha.eurekaselect.com" ] ]
        request_cookies
        0 of 0
        array:1 [ "wayfindertarget" => null ]
        response_headers
        0 of 0
        array:5 [ "content-type" => array:1 [ 0 => "text/html; charset=UTF-8" ] "cache-control" => array:1 [ 0 => "no-cache, private" ] "date" => array:1 [ 0 => "Sun, 23 Feb 2025 21:58:51 GMT" ] "set-cookie" => array:2 [ 0 => "XSRF-TOKEN=eyJpdiI6IjFzK0ZWY2dKUmxhbTVxQVAwQk1Ub2c9PSIsInZhbHVlIjoibVo2b3M0NUxrdU9JTzdJUS8reWJHWU1RUlNBd3ZPczNFK3NKaER1RWtVNGp2SmVydlVvbm5wQW1ydzZkUWZsOG90Q2xZcjRUT3pRNjhDNk1pUjJoK2orNTgxa0ZFci9BUXVJUExnZytXWDQ4Ti9xNkY4dU9zNEhOT1d2eHNnb2MiLCJtYWMiOiI3ZmQ0OTkxN2Y3YmRiYzJmZmNlMGU3MDA3ZmU0YWM1OWE4ZWQ2OTBkMjBhMDAxNjBjNTk1NzY4OWNiMjhiNDU1IiwidGFnIjoiIn0%3D; expires=Wed, 26 Feb 2025 09:58:51 GMT; Max-Age=216000; path=/; secure; samesite=laxXSRF-TOKEN=eyJpdiI6IjFzK0ZWY2dKUmxhbTVxQVAwQk1Ub2c9PSIsInZhbHVlIjoibVo2b3M0NUxrdU9JTzdJUS8reWJHWU1RUlNBd3ZPczNFK3NKaER1RWtVNGp2SmVydlVvbm5wQW1ydzZkUWZsOG90Q2xZc" 1 => "alphaeurekaselectnet_session=eyJpdiI6InlBS2RhUUZTSU1qVXQyTndyV3d6U2c9PSIsInZhbHVlIjoiaVR1ZW1JNUROcDZoSVZ1OWNOZnJTK0dVcnhhTGt1MFlablN6S0NheU5TRWlLOTN2cmIrVlVtRzIxaDJqSlo0SW16MDFjZFJ2bkZnNVJpSVNPL2w3VmNiZnVBTmQ2RXdpMkdSLys5TlhhdG5DU3E5YnNVVko5VitqUzJKNzdWeUUiLCJtYWMiOiIwYzUyYjIxODBiNGU2MTZmZmRjMjQ3NWUzNmNhY2ZjYjI5YTY1ODUxZjhjY2U2ZGNjODk1YjIwZjhjN2RlMzI2IiwidGFnIjoiIn0%3D; path=/; secure; httponly; samesite=laxalphaeurekaselectnet_session=eyJpdiI6InlBS2RhUUZTSU1qVXQyTndyV3d6U2c9PSIsInZhbHVlIjoiaVR1ZW1JNUROcDZoSVZ1OWNOZnJTK0dVcnhhTGt1MFlablN6S0NheU5TRWlLOTN2cmIrVlVtRzI" ] "Set-Cookie" => array:2 [ 0 => "XSRF-TOKEN=eyJpdiI6IjFzK0ZWY2dKUmxhbTVxQVAwQk1Ub2c9PSIsInZhbHVlIjoibVo2b3M0NUxrdU9JTzdJUS8reWJHWU1RUlNBd3ZPczNFK3NKaER1RWtVNGp2SmVydlVvbm5wQW1ydzZkUWZsOG90Q2xZcjRUT3pRNjhDNk1pUjJoK2orNTgxa0ZFci9BUXVJUExnZytXWDQ4Ti9xNkY4dU9zNEhOT1d2eHNnb2MiLCJtYWMiOiI3ZmQ0OTkxN2Y3YmRiYzJmZmNlMGU3MDA3ZmU0YWM1OWE4ZWQ2OTBkMjBhMDAxNjBjNTk1NzY4OWNiMjhiNDU1IiwidGFnIjoiIn0%3D; expires=Wed, 26-Feb-2025 09:58:51 GMT; path=/; secureXSRF-TOKEN=eyJpdiI6IjFzK0ZWY2dKUmxhbTVxQVAwQk1Ub2c9PSIsInZhbHVlIjoibVo2b3M0NUxrdU9JTzdJUS8reWJHWU1RUlNBd3ZPczNFK3NKaER1RWtVNGp2SmVydlVvbm5wQW1ydzZkUWZsOG90Q2xZc" 1 => "alphaeurekaselectnet_session=eyJpdiI6InlBS2RhUUZTSU1qVXQyTndyV3d6U2c9PSIsInZhbHVlIjoiaVR1ZW1JNUROcDZoSVZ1OWNOZnJTK0dVcnhhTGt1MFlablN6S0NheU5TRWlLOTN2cmIrVlVtRzIxaDJqSlo0SW16MDFjZFJ2bkZnNVJpSVNPL2w3VmNiZnVBTmQ2RXdpMkdSLys5TlhhdG5DU3E5YnNVVko5VitqUzJKNzdWeUUiLCJtYWMiOiIwYzUyYjIxODBiNGU2MTZmZmRjMjQ3NWUzNmNhY2ZjYjI5YTY1ODUxZjhjY2U2ZGNjODk1YjIwZjhjN2RlMzI2IiwidGFnIjoiIn0%3D; path=/; secure; httponlyalphaeurekaselectnet_session=eyJpdiI6InlBS2RhUUZTSU1qVXQyTndyV3d6U2c9PSIsInZhbHVlIjoiaVR1ZW1JNUROcDZoSVZ1OWNOZnJTK0dVcnhhTGt1MFlablN6S0NheU5TRWlLOTN2cmIrVlVtRzI" ] ]
        session_attributes
        0 of 0
        array:5 [ "_token" => "Wu0t6w6oFrXwYSdOKrA2ttnYuSQJE3xmxaZWFUka" "uc_cart_id" => "a4ff9f5d16b59bdb5577eb20140616d7" "_previous" => array:1 [ "url" => "http://alpha.eurekaselect.com/article/103135" ] "_flash" => array:2 [ "old" => [] "new" => [] ] "PHPDEBUGBAR_STACK_DATA" => [] ]
        ClearShow all
        Date ↕MethodURLData
        #12025-02-23 21:58:51GET/article/103135312351